Status:
COMPLETED
Avascular Bone Necrosis in Sickle Cell Disease: a Pediatric Study.
Lead Sponsor:
San Luigi Gonzaga Hospital
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
7-17 years
Brief Summary
Avascular necrosis (AVN) is a serious complication of sickle cell disease, especially in pediatric patients where the prevalence is between 3% and 8% and are more frequent in patients with multiple va...
Eligibility Criteria
Inclusion
- Female or male patients diagnosed with sickle cell anemia (HbSS, HbS/β0, HbS/β+, HbSC) with or without known avascular lesions
- Age ≥ 7 and \< 18 years at the moment of signed consent
- Written informed consent/assent, according to local guidelines, signed by patient and/or guidelines, signed by the patient and/or at least one parent or legal guardian
Exclusion
- \- Any contraindication to perform Nuclear Magnetic Resonance Magnetic Resonance Imaging (MRI)
- Inability to obtain informed consent/assent
Key Trial Info
Start Date :
March 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 27 2021
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05203991
Start Date
March 18 2021
End Date
October 27 2021
Last Update
January 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU San Luigi Gonzaga
Orbassano, Torino, Italy, 10043